Human IL1B/IL-1/IL1-BETA ORF/cDNA clone-Adeno-associate virus(AAV) particle (NM_000576.3)

Cat. No.: vGMAAV001962

Pre-made Human IL1B/IL-1/IL1-BETA Adeno-associated virus particle for IL1B in-vivo study, mechanism of action (MOA) research and IL1B-associated gene therapy development.

At GM Vector Core (GMVC), we stand at the forefront of custom AAV development and produce distinct grades of AAVs employing state-of-the-art methodologies. Uncover more about our expertise.

Target products collection

Go to IL-1 Beta/IL1B/IL1B/IL-1 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name AAV serotype AAV Grade AAV quantity
vGMAAV001962 Human IL1B Adeno-associate virus(AAV) particle AAV1, AAV2, AAV2 variant (Y444F), AAV2 variant (Y272F, Y444F, Y500F, Y730F), AAV2 variant (Y444F, Y730F, Y500F, Y272F, Y704F, Y252F), AAV2 variant(AAV2.7m8), AAV5, AAV6, AAV8, AAV8-1m, AAV8-2m, AAV8 variant (Y733F, Y447F, Y275), AAV9, AAV-Rh.10, AAV-DJ, AAV-DJ/8, AAV-Retro (Retrograde), AAV9-PHP.B, AAV9-PHP.eB, AAV9-PHP.S, AAV-BR1, AAV-2i8, AAV-SIG, AAV-VEC, AAV4, AAV6.2, AAV6.2FF Pilot Grade 1.0E+12VG/ml
5.0E+12VG/ml
1E+13VG/ml
5E+13VG/ml
1E+14VG/ml
Research Grade 1.0E+12VG/ml
5.0E+12VG/ml
1E+13VG/ml
5E+13VG/ml
1E+14VG/ml
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMAAV001962
Gene Name IL1B
Accession Number NM_000576.3
Gene ID 3553
Species Human
Product Type Adeno-associate virus(AAV) particle (overexpression)
Insert Length 810 bp
Gene Alias IL-1,IL1-BETA,IL1beta,IL1F2
Fluorescent Reporter Null
Mammalian Cell Selection Null
Fusion Tag Null
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGCAGAAGTACCTGAGCTCGCCAGTGAAATGATGGCTTATTACAGTGGCAATGAGGATGACTTGTTCTTTGAAGCTGATGGCCCTAAACAGATGAAGTGCTCCTTCCAGGACCTGGACCTCTGCCCTCTGGATGGCGGCATCCAGCTACGAATCTCCGACCACCACTACAGCAAGGGCTTCAGGCAGGCCGCGTCAGTTGTTGTGGCCATGGACAAGCTGAGGAAGATGCTGGTTCCCTGCCCACAGACCTTCCAGGAGAATGACCTGAGCACCTTCTTTCCCTTCATCTTTGAAGAAGAACCTATCTTCTTCGACACATGGGATAACGAGGCTTATGTGCACGATGCACCTGTACGATCACTGAACTGCACGCTCCGGGACTCACAGCAAAAAAGCTTGGTGATGTCTGGTCCATATGAACTGAAAGCTCTCCACCTCCAGGGACAGGATATGGAGCAACAAGTGGTGTTCTCCATGTCCTTTGTACAAGGAGAAGAAAGTAATGACAAAATACCTGTGGCCTTGGGCCTCAAGGAAAAGAATCTGTACCTGTCCTGCGTGTTGAAAGATGATAAGCCCACTCTACAGCTGGAGAGTGTAGATCCCAAAAATTACCCAAAGAAGAAGATGGAAAAGCGATTTGTCTTCAACAAGATAGAAATCAATAACAAGCTGGAATTTGAGTCTGCCCAGTTCCCCAACTGGTACATCAGCACCTCTCAAGCAGAAAACATGCCCGTCTTCCTGGGAGGGACCAAAGGCGGCCAGGATATAACTGACTTCACCATGCAATTTGTGTCTTCCTAA
ORF Protein Sequence MAEVPELASEMMAYYSGNEDDLFFEADGPKQMKCSFQDLDLCPLDGGIQLRISDHHYSKGFRQAASVVVAMDKLRKMLVPCPQTFQENDLSTFFPFIFEEEPIFFDTWDNEAYVHDAPVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Biosimilar GMP-Bios-ab-241 Pre-Made Gevokizumab biosimilar, Whole mAb, Anti-IL1B Antibody: Anti-IL-1/IL1-BETA/IL1F2/IL1beta therapeutic antibody
    Biosimilar GMP-Bios-ab-091 Pre-Made Canakinumab biosimilar, Whole mAb, Anti-IL1B Antibody: Anti-IL-1/IL1-BETA/IL1F2/IL1beta therapeutic antibody
    Biosimilar GMP-Bios-INN-973 Pre-Made Rilonacept Biosimilar, Fusion Protein targeting IL1B fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting IL-1/IL1-BETA/IL1F2/IL1beta
    Biosimilar GMP-Bios-ab-331 Pre-Made Lutikizumab biosimilar, Bispecific Dual Variable Domain IG, Anti-IL1A;IL1B Antibody: Anti-IL1/IL-1A/IL1F1/IL1-ALPHA/IL-1 alpha;IL-1/IL1-BETA/IL1F2/IL1beta therapeutic antibody
    Target Antibody GM-Tg-g-T42000-Ab Anti-IL1B/ IL-1/ IL1-BETA functional antibody
    Target Antigen GM-Tg-g-T42000-Ag IL1B protein
    Cytokine cks-Tg-g-GM-T42000 Interleukin-1 Beta (Il1b) protein & antibody
    ORF Viral Vector pGMAD000735 Human IL1B Adenovirus plasmid
    ORF Viral Vector pGMAAV001962 Human IL1B Adeno-associate virus(AAV) plasmid
    ORF Viral Vector pGMAP000158 Human IL1B Adenovirus plasmid
    ORF Viral Vector pGMLP-IL-002 Human IL1B Lentivirus plasmid
    ORF Viral Vector pGMAP-IL-085 Human IL1B Adenovirus plasmid
    ORF Viral Vector pGMPC001847 Human IL1B Mammalian (Non-Viral Vector) plasmid
    ORF Viral Vector vGMAD000735 Human IL1B Adenovirus particle
    ORF Viral Vector vGMAAV001962 Human IL1B Adeno-associate virus(AAV) particle
    ORF Viral Vector vGMAP000158 Human IL1B Adenovirus particle
    ORF Viral Vector vGMLP-IL-002 Human IL1B Lentivirus particle
    ORF Viral Vector vGMAP-IL-085 Human IL1B Adenovirus particle


    Target information

    Target ID GM-T42000
    Target Name IL-1 Beta/IL1B
    Gene Group Identifier
    （Target Gene ID in Homo species)         		3553
    Gene ID 16176 (Mus musculus), 24494 (Rattus norvegicus), 281251 (Bos taurus), 3553 (Homo sapiens)
    403974 (Canis lupus familiaris), 704701 (Macaca mulatta), 768274 (Felis catus)
    Gene Symbols & Synonyms Il1b,IL1B,Il-1b,IL-1beta,IL-1F2,IL-1,IL1F2,IL1beta,IL1-BETA
    Target Alternative Names Catabolin,IL-1,IL-1 Beta,IL-1 beta,IL-1F2,IL-1beta,IL1-BETA,IL1B,IL1F2,IL1beta,Il-1b,Il1b,Interleukin-1 beta
    Uniprot Accession P01584,P09428,P10749,P41687,P48090,Q28292,Q63264
    Additional SwissProt Accessions: P10749,Q63264,P09428,P01584,Q28292,P48090,P41687
    Uniprot Entry Name
    Protein Sub-location Secreted Protein/Potential Cytokines
    Category Therapeutics Target, Immuno-oncology Target, INN Index, Cytokine Target
    Disease cancer, Breast Cancer, prostate cancer
    Disease from KEGG Antifolate resistance, MAPK signaling pathway, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, C-type lectin receptor signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Th17 cell differentiation, TNF signaling pathway, Inflammatory mediator regulation of TRP channels, AGE-RAGE signaling pathway in diabetic complications, Alcoholic liver disease, Type I diabetes mellitus, Alzheimer disease, Pathogenic Escherichia coli infection, Pertussis, Legionellosis, Yersinia infection, Leishmaniasis, Chagas disease, African trypanosomiasis, Malaria, Amoebiasis, Tuberculosis, Measles, Human cytomegalovirus infection, Influenza A, Inflammatory bowel disease, Rheumatoid arthritis, Graft-versus-host disease, Lipid and atherosclerosis, Fluid shear stress and atherosclerosis
    Gene Ensembl ENSMUSG00000027398, ENSBTAG00000001321, ENSG00000125538, ENSCAFG00845011661, ENSMMUG00000061716
    Target Classification Checkpoint-Immuno Oncology


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.